Phase II trial of mitoxantrone in patients with hepatocellular carcinoma.
Yoshida
T
T
Department of Internal Medicine, National Cancer Center Hospital, Tokyo, Japan.
Okazaki
N
N
Yoshino
M
M
Ohkura
H
H
Miyamoto
K
K
Shimada
Y
Y
D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced
D008942:Mitoxantrone